SCHEMBL25428430

SCHEMBL25428430

FC(F)(F)c1ccc(Sc2nccnc2-c2ccc3[nH]nnc3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 7/20 0.36
▸ CCNB2 O95067 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CCNB1 P14635 1/20 0.36
▸ GSK3A P49840 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ CCNB3 Q8WWL7 1/20 0.36
▸ MAP2K4 P45985 3/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ MAPKAPK3 Q16644 2/20 0.35
▸ MAPK6 Q16659 2/20 0.35
▸ MAPKAPK2 P49137 1/20 0.35
▸ KIF11 P52732 1/20 0.34
▸ HAO1 Q9UJM8 1/20 0.33
▸ TOP1 P11387 1/20 0.32
▸ TRPA1 O75762 1/20 0.32
▸ MAPK13 O15264 1/20 0.31
▸ RAF1 P04049 1/20 0.31
▸ MAPK12 P53778 1/20 0.31
▸ MAPK11 Q15759 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30544022 1.00 TRPV1 (0.36) TRPV1CCNB2CDK1CCNB1GSK3A
SCHEMBL25341570 0.84 CCNB2 (0.36) TRPV1CCNB2CDK1CCNB1GSK3A
SCHEMBL25430336 0.82 CCNB2 (0.33) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL25428892 0.78 TRPV1 (0.37) TRPV1CCNB2CDK1CCNB1GSK3A
SCHEMBL30544130 0.78 TRPV1 (0.37) TRPV1CCNB2CDK1CCNB1GSK3A
SCHEMBL25430912 0.77 TRPV1 (0.47) TRPV1
SCHEMBL25341274 0.74 KIF11 (0.50) TRPV1CCNB2CDK1CCNB1GSK3A
SCHEMBL25340553 0.74 KIF11 (0.50) TRPV1CCNB2CDK1CCNB1GSK3A
SCHEMBL25973977 0.74 TRPV1 (0.39) TRPV1CCNB2CDK1CCNB1GSK3A
SCHEMBL25974048 0.73 TRPV1 (0.37) TRPV1CCNB2CDK1CCNB1GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback